{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:21:08Z","timestamp":1794360068291,"version":"4.9.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13313-7","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T20:48:19Z","timestamp":1776718099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Global and regional trends in multidrug- or rifampicin-resistant tuberculosis, 2000\u20132024 with forecasts to 2030: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Ahmed","family":"Hossain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer El","family":"Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Almheiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Almheiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Alameddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"13313_CR1","unstructured":"World Health Organization. Global tuberculosis report 2023. Geneva: WHO; 2023. Available from: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2023."},{"key":"13313_CR2","doi-asserted-by":"publisher","unstructured":"Chen Z, Wang T, Du J, Sun L, Wang G, Ni R, et al. Decoding the WHO global tuberculosis report 2024: a critical analysis of global and Chinese key data. Zoonoses. 2025;5(1). https:\/\/doi.org\/10.15212\/ZOONOSES-2024-0061.","DOI":"10.15212\/ZOONOSES-2024-0061"},{"key":"13313_CR3","doi-asserted-by":"publisher","unstructured":"Seung KJ, Keshavjee S, Rich ML. Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harb Perspect Med. 2015, Apr, 27;5(9):a017863. https:\/\/doi.org\/10.1101\/cshperspect.a017863. PMID: 25918181; PMCID: PMC4561400.","DOI":"10.1101\/cshperspect.a017863"},{"issue":"5","key":"13313_CR4","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/pathogens12050652","volume":"12","author":"J Seeberg","year":"2023","unstructured":"Seeberg J. An epidemic of drug resistance: tuberculosis in the twenty-first century. Pathogens. 2023, Apr, 27;12(5):652. https:\/\/doi.org\/10.3390\/pathogens12050652. PMID: 37242322; PMCID: PMC10224347.","journal-title":"Pathogens"},{"issue":"6624","key":"13313_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1126\/science.abq2787","volume":"378","author":"Q Liu","year":"2022","unstructured":"Liu Q, Zhu J, Dulberger CL, Stanley S, Wilson S, Chung ES, et al. Tuberculosis treatment failure associated with evolution of antibiotic resilience. Science. 2022, Dec, 9;378(6624):1111\u201318. https:\/\/doi.org\/10.1126\/science.abq2787. Epub 2022 Dec 8. PMID: 36480634; PMCID: PMC9968493.","journal-title":"Science"},{"issue":"2","key":"13313_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S1473-3099(19)30568-7","volume":"20","author":"A Dadu","year":"2020","unstructured":"Dadu A, Hovhannesyan A, Ahmedov S, van der Werf MJ, Dara M. Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data. The Lancet Infect Dis. 2020, Feb;20(2):250\u201358. https:\/\/doi.org\/10.1016\/S1473-3099(19)30568-7. Epub 2019 Nov 26. PMID: 31784371.","journal-title":"The Lancet Infect Dis"},{"issue":"2","key":"13313_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S2352-4642(24)00330-4","volume":"9","author":"AJ Garcia-Prats","year":"2025","unstructured":"Garcia-Prats AJ, Garcia-Cremades M, Cox V, Kredo T, Dunbar R, Schaaf HS, et al. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis. LancetThe Lancet Child Adolesc Health. 2025, Feb;9(2):100\u201311. doi: 10.1016\/S2352-4642(24)00330-4.Erratum in:Lancet Child Adolesc Health.2025 Mar; 9(3):e9.doi https:\/\/doi.org\/10.1016\/S2352-4642(24)00330-4. PMID: 39855750.","journal-title":"LancetThe Lancet Child Adolesc Health"},{"issue":"10411","key":"13313_CR8","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/S0140-6736(23)01379-X","volume":"402","author":"M Reid","year":"2023","unstructured":"Reid M, Agbassi YJP, Arinaminpathy N, Bercasio A, Bhargava A, Bhargava M, et al. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on tuberculosis. Lancet. 2023, Oct, 21;402(10411):1473\u201398. https:\/\/doi.org\/10.1016\/S0140-6736(23)01379-X. Epub 2023 Sep 13. PMID: 37716363.","journal-title":"Lancet"},{"issue":"9","key":"13313_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S2213-2600(19)30263-2","volume":"7","author":"K Dheda","year":"2019","unstructured":"Dheda K, Gumbo T, Maartens G, Dooley KE, Murray M, Furin J, et al. Lancet Respiratory Medicine drug-resistant tuberculosis Commission group. The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis. The Lancet Respir Med. 2019, Sep;7(9):820\u201326. https:\/\/doi.org\/10.1016\/S2213-2600(19)30263-2. PMID: 31486393.","journal-title":"The Lancet Respir Med"},{"issue":"3","key":"13313_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijmyco.2016.08.008","volume":"5","author":"MM Ahmed","year":"2016","unstructured":"Ahmed MM, Velayati AA, Mohammed SH. Epidemiology of multidrug-resistant, extensively drug resistant, and totally drug resistant tuberculosis in middle East countries. Int J Mycobacteriol. 2016, Sep;5(3):249\u201356. https:\/\/doi.org\/10.1016\/j.ijmyco.2016.08.008. Epub 2016 Sep 2. PMID: 27847005.","journal-title":"Int J Mycobacteriol"},{"key":"13313_CR11","doi-asserted-by":"publisher","unstructured":"Alibrahim A, Alqahtani H, Thirunavukkarasu A, Qazi I. Prevalence, patterns, and determinants of drug-resistant tuberculosis in Gulf cooperation council countries: an updated systematic review. PeerJ. 2024, Nov;12(12):e18628. https:\/\/doi.org\/10.7717\/peerj.18628. PMID: 39619190; PMCID: PMC11608559.","DOI":"10.7717\/peerj.18628"},{"issue":"8","key":"13313_CR12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1473-3099(19)30307-X","volume":"19","author":"GM Knight","year":"2019","unstructured":"Knight GM, McQuaid CF, Dodd PJ, Houben RMGJ. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling. The Lancet Infect Dis. 2019, Aug;19(8):903\u201312. https:\/\/doi.org\/10.1016\/S1473-3099(19)30307-X. Epub 2019 Jul 4. Erratum in:Lancet Infect Dis.2020 Apr; 20(4):e50.doi 10.1016\/S1473-3099(20)30087-6. PMID: 31281059; PMCID: PMC6656782.","journal-title":"The Lancet Infect Dis"},{"issue":"1","key":"13313_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12879-024-09079-5","volume":"24","author":"H Lv","year":"2024","unstructured":"Lv H, Zhang X, Zhang X, Bai J, You S, Li X, et al. Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019. BMC Infect Dis. 2024, Feb, 22;24(1):243. https:\/\/doi.org\/10.1186\/s12879-024-09079-5. PMID: 38388352; PMCID: PMC10885623.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13313_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12879-017-2323-y","volume":"17","author":"S Eshetie","year":"2017","unstructured":"Eshetie S, Gizachew M, Dagnew M, Kumera G, Woldie H, Ambaw F, et al. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. BMC Infect Dis. 2017, Mar, 20;17(1):219. https:\/\/doi.org\/10.1186\/s12879-017-2323-y. PMID: 28320336; PMCID: PMC5360058.","journal-title":"BMC Infect Dis"},{"key":"13313_CR15","doi-asserted-by":"publisher","unstructured":"Molla KA, Reta MA, Ayene YY. Prevalence of multidrug-resistant tuberculosis in East Africa: a systematic review and meta-analysis. PLoS One. 2022, Jun, 30;17(6):e0270272. https:\/\/doi.org\/10.1371\/journal.pone.0270272. PMID: 35771884; PMCID: PMC9246177.","DOI":"10.1371\/journal.pone.0270272"},{"key":"13313_CR16","unstructured":"Hossain A. Hind Abdelrazaq Saif Buhair Almheiri, Abeer El Asmar, Amna Abdelrazaq Saif Behair Almheiri. Global prevalence and geographic distribution of multidrug-resistant tuberculosis and HIV coinfection among tuberculosis patients: a systematic review and meta-analysis. PROSPERO. 2025 CRD420251018331. Available from https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251018331."},{"key":"13313_CR17","unstructured":"Our World in data - processed by our World in data. \u201cWorld regions according to the World Health Organization\u201d [dataset]. Our World in data, \u201cregions\u201d. Original data. June 28, 2025 from (archived on June 24, 2025). https:\/\/archive.ourworldindata.org\/20250624-125417\/grapher\/who-regions.html."},{"key":"13313_CR18","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"1","key":"13313_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","volume":"14","author":"CK-L Lo","year":"2014","unstructured":"Lo CK-L, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments. BMC Med Res Methodol. 2014, Apr;14(1):45. https:\/\/doi.org\/10.1186\/1471-2288-14-45. PMID: 24690082; PMCID: PMC4021422.","journal-title":"BMC Med Res Methodol"},{"key":"13313_CR20","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.eclinm.2021.100770","volume":"33","author":"A Hossain","year":"2021","unstructured":"Hossain A, Nasrullah SM, Tasnim Z, Hasan MK, Hasan MM. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the Usa and East Asia: a systematic review and meta-analysis. EClinicalMedicine. 2021, Mar;33:100770. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100770. Epub 2021 Mar 8. PMID: 33718853; PMCID: PMC7938754.","journal-title":"EClinicalMedicine"},{"key":"13313_CR21","unstructured":"The Stop TB Parterships High Burden Countries For Tuberculosis. June 28, 2025. Available from: https:\/\/www.stoptb.org\/high-burden-countries-tuberculosis."},{"issue":"1","key":"13313_CR22","first-page":"24","volume":"14","author":"RC Brito","year":"2010","unstructured":"Brito RC, Mello FC, Andrade MK, Oliveira H, Costa W, Matos HJ, et al. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis. 2010 Jan;14(1):24\u201333. PMID: 20003691.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"13313_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1164\/rccm.200907-0989OC","volume":"181","author":"NR Gandhi","year":"2010","unstructured":"Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, et al. Tugela, ferry care and research (TF CARES) collaboration. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010, Jan, 1;181(1):80\u201386. https:\/\/doi.org\/10.1164\/rccm.200907-0989OC. Epub 2009 Oct 15. PMID: 19833824.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"13313_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijmyco.2012.07.001","volume":"1","author":"R Macedo","year":"2012","unstructured":"Macedo R, Antunes AF, Villar M, Portugal I. Multidrug and extensively drug-resistant tuberculosis in Lisbon and Vale do Tejo, Portugal, from 2008 to 2010. Int J Mycobacteriol. 2012 Sep;1(3):131\u201336. https:\/\/doi.org\/10.1016\/j.ijmyco.2012.07.001. Epub 2012 Aug 13. PMID: 26787208.","journal-title":"Int J Mycobacteriol"},{"issue":"1","key":"13313_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3201\/eid1801.110850","volume":"18","author":"E Sanchez-Padilla","year":"2012","unstructured":"Sanchez-Padilla E, Dlamini T, Ascorra A, R\u00fcsch-Gerdes S, Tefera ZD, Calain P, et al. High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009\u20132010. Emerg Infect Dis. 2012 Jan;18(1):29\u201337. https:\/\/doi.org\/10.3201\/eid1801.110850. PMID: 22260950; PMCID: PMC3310109.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"13313_CR26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1590\/s0074-02762012000600009","volume":"107","author":"AGV Coelho","year":"2012","unstructured":"Coelho AGV, Zamarioli LA, Telles MA, Ferrazoli L, Waldman EA. A study of multidrug-resistant tuberculosis in risk groups in the city of Santos, S\u00e3o Paulo, Brazil. Mem Inst Oswaldo Cruz. 2012 Sep;107(6):760\u201366. https:\/\/doi.org\/10.1590\/s0074-02762012000600009. PMID: 22990966; PMCID: PMC3749909.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"23","key":"13313_CR27","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","volume":"366","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012 Jun 7;366(23):2161\u201370. https:\/\/doi.org\/10.1056\/NEJMoa1108789. PMID: 22670902.","journal-title":"N Engl J Med"},{"issue":"7","key":"13313_CR28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/thoraxjnl-2011-200018","volume":"67","author":"L Liang","year":"2012","unstructured":"Liang L, Wu Q, Gao L, Hao Y, Liu C, Xie Y, et al. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China. Thorax. 2012 Jul;67(7):632\u201338. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200018. Epub 2012 Mar 8. PMID: 22403070.","journal-title":"Thorax"},{"issue":"6","key":"13313_CR29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.5588\/ijtld.11.0522","volume":"16","author":"B Tessema","year":"2012","unstructured":"Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Int J Tuberc Lung Dis. 2012, Jun;16(6):805\u201311. https:\/\/doi.org\/10.5588\/ijtld.11.0522. Epub 2012 Feb 29. PMID: 22390880.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13313_CR30","doi-asserted-by":"publisher","unstructured":"Minion J, Gallant V, Wolfe J, Jamieson F, Long R. Multidrug and extensively drug-resistant tuberculosis in Canada 1997\u20132008: demographic and disease characteristics. PLoS One. 2013;8(1):e53466. https:\/\/doi.org\/10.1371\/journal.pone.0053466. Epub 2013 Jan 9. PMID: 23326436; PMCID: PMC3541271.","DOI":"10.1371\/journal.pone.0053466"},{"issue":"1","key":"13313_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1471-2334-13-137","volume":"13","author":"S Sethi","year":"2013","unstructured":"Sethi S, Mewara A, Dhatwalia SK, Singh H, Yadav R, Singh K, et al. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India. BMC Infect Dis. 2013, Mar;13(1):137. https:\/\/doi.org\/10.1186\/1471-2334-13-137. PMID: 23497169; PMCID: PMC3610146.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"13313_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.5588\/ijtld.12.0703","volume":"17","author":"van den Hof S","year":"2013","unstructured":"van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, et al. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan. Int J Tuberc Lung Dis. 2013;17(4):526\u201331. https:\/\/doi.org\/10.5588\/ijtld.12.0703. PMID: 23485387.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13313_CR33","doi-asserted-by":"publisher","unstructured":"Hang NTL, Maeda S, Lien LT, Thuong PH, Hung NV, Thuy TB, et al. Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors. PLoS One. 2013, Aug, 13;8(8):e71867. https:\/\/doi.org\/10.1371\/journal.pone.0071867. PMID: 23967255; PMCID: PMC3742467.","DOI":"10.1371\/journal.pone.0071867"},{"issue":"1","key":"13313_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.5588\/ijtld.12.0344","volume":"17","author":"H Satti","year":"2013","unstructured":"Satti H, McLaughlin MM, Seung KJ, Becerra MC, Keshavjee S. High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2013, Jan;17(1):100\u201306. https:\/\/doi.org\/10.5588\/ijtld.12.0344. PMID: 23232009.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13313_CR35","doi-asserted-by":"publisher","unstructured":"Tang S, Tan S, Yao L, Li F, Li L, Guo X, et al. Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation. PLoS One. 2013, Dec, 5;8(12):e82943. https:\/\/doi.org\/10.1371\/journal.pone.0082943. PMID: 24349402; PMCID: PMC3857781.","DOI":"10.1371\/journal.pone.0082943"},{"key":"13313_CR36","doi-asserted-by":"publisher","unstructured":"Ulmasova DJ, Uzakova G, Tillyashayhov MN, Turaev L, van Gemert W, Hoffmann H, et al. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011. Eurosurveillance. 18(42):20609. https:\/\/doi.org\/10.2807\/1560-7917.es2013.18.42.20609. 2013 Oct 17. PMID: 24176581.","DOI":"10.2807\/1560-7917.es2013.18.42.20609"},{"key":"13313_CR37","doi-asserted-by":"publisher","unstructured":"Lukoye D, Adatu F, Musisi K, Kasule GW, Were W, Odeke R, et al. Anti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national survey. PLoS One. 2013, Aug, 1;8(8):e70763. https:\/\/doi.org\/10.1371\/journal.pone.0070763. PMID: 23936467; PMCID: PMC3731251.","DOI":"10.1371\/journal.pone.0070763"},{"issue":"1","key":"13313_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2471\/BLT.12.104588","volume":"91","author":"A Skrahina","year":"2013","unstructured":"Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, Hoffner S, et al. Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors. Bull. World Health Organ. 2013, Jan, 1;91(1):36\u201345. https:\/\/doi.org\/10.2471\/BLT.12.104588. Epub 2012 Nov 26. PMID: 23397349; PMCID: PMC3537245.","journal-title":"Bull. World Health Organ"},{"issue":"10","key":"13313_CR39","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.5588\/ijtld.14.0192","volume":"18","author":"Z Mor","year":"2014","unstructured":"Mor Z, Goldblatt D, Kaidar-Shwartz H, Cedar N, Rorman E, Chemtob D. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes. Int J Tuberc Lung Dis. 2014, Oct;18(10):1195\u2013201. https:\/\/doi.org\/10.5588\/ijtld.14.0192. PMID: 25216833.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"13313_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jinf.2013.09.034","volume":"68","author":"FA Post","year":"2014","unstructured":"Post FA, Grint D, Werlinrud AM, Panteleev A, Riekstina V, Malashenkov EA, et al. Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe. J Infect. 2014, Mar;68(3):259\u201363. https:\/\/doi.org\/10.1016\/j.jinf.2013.09.034. Epub 2013 Nov 16. PMID: 24247067.","journal-title":"J Infect"},{"issue":"1","key":"13313_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3201\/eid2001.130732","volume":"20","author":"JZ Metcalfe","year":"2014","unstructured":"Metcalfe JZ, Makumbirofa S, Makamure B, Sandy C, Bara W, Mungofa S, et al. Drug-resistant tuberculosis in high-risk groups, Zimbabwe. Emerg Infect Dis. 2014, Jan;20(1):135\u201337. https:\/\/doi.org\/10.3201\/eid2001.130732. PMID: 24377879; PMCID: PMC3884722.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"13313_CR42","doi-asserted-by":"publisher","first-page":"406","DOI":"10.5588\/ijtld.14.0838","volume":"19","author":"R van Altena","year":"2015","unstructured":"van Altena R, de Vries G, Haar CH, de Lange WC, Magis-Escurra C, van den Hof S, et al. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000\u20132009. Int J Tuberc Lung Dis. 2015, Apr;19(4):406\u201312. https:\/\/doi.org\/10.5588\/ijtld.14.0838. PMID: 25859995.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"13313_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12879-015-1202-7","volume":"15","author":"F Mekonnen","year":"2015","unstructured":"Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infect Dis. 2015, Oct;15(1):461. https:\/\/doi.org\/10.1186\/s12879-015-1202-7. PMID: 26503269; PMCID: PMC4624367.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"13313_CR44","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3201\/eid2111.150813","volume":"21","author":"JV Ershova","year":"2015","unstructured":"Ershova JV, Volchenkov GV, Kaminski DA, Somova TR, Kuznetsova TA, Kaunetis NV, et al. Epidemiology of primary multidrug-resistant tuberculosis, Vladimir Region, Russia. Emerg Infect Dis. 2015, Nov;21(11):2048\u201351. https:\/\/doi.org\/10.3201\/eid2111.150813. PMID: 26488585; PMCID: PMC4622259.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"13313_CR45","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s12889-015-1955-3","volume":"15","author":"K Abdella","year":"2015","unstructured":"Abdella K, Abdissa K, Kebede W, Abebe G. Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health. 2015, Jul;15(1):599. https:\/\/doi.org\/10.1186\/s12889-015-1955-3. PMID: 26135909; PMCID: PMC4489121.","journal-title":"BMC Public Health"},{"issue":"2","key":"13313_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.13189\/ujph.2015.030203","volume":"3","author":"F Tadesse","year":"2015","unstructured":"Tadesse F. Risk factors for multi-drug resistant tuberculosis in Addis Ababa, Ethiopia. ujph. 2015;3(2):65\u201370. https:\/\/doi.org\/10.13189\/ujph.2015.030203.","journal-title":"ujph"},{"key":"13313_CR47","doi-asserted-by":"publisher","unstructured":"Selvakumar N, Kumar V, Balaji S, Prabuseenivasan S, Radhakrishnan R, Sekar G, et al. High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. PLoS One. 2015, Mar, 4;10(3):e0117421. https:\/\/doi.org\/10.1371\/journal.pone.0117421. PMID: 25738956; PMCID: PMC4349813.","DOI":"10.1371\/journal.pone.0117421"},{"key":"13313_CR48","doi-asserted-by":"publisher","unstructured":"Salindri AD, Kipiani M, Kempker RR, Gandhi NR, Darchia L, Tukvadze N, et al. Diabetes reduces the rate of sputum culture conversion in patients with newly diagnosed multidrug-resistant tuberculosis. Open Forum Infect Dis. 2016, Jun, 16;3(3):ofw126. https:\/\/doi.org\/10.1093\/ofid\/ofw126. PMID: 27419188; PMCID: PMC4942763.","DOI":"10.1093\/ofid\/ofw126"},{"issue":"6","key":"13313_CR49","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3349\/ymj.2016.57.6.1508","volume":"57","author":"S Lee","year":"2016","unstructured":"Lee S, Lee SH, Mok JH, Lee SJ, Kim KH, Lee JE, et al. Is Multi-drug resistant tuberculosis more Prevalent in HIV-Infected patients in Korea? Yonsei Med J. 2016, Nov;57(6):1508\u201310. https:\/\/doi.org\/10.3349\/ymj.2016.57.6.1508. PMID: 27593882; PMCID: PMC5011286.","journal-title":"Yonsei Med J"},{"issue":"1","key":"13313_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12879-016-1766-x","volume":"16","author":"EI Namburete","year":"2016","unstructured":"Namburete EI, Tivane I, Lisboa M, Passeri M, Pocente R, Ferro JJ, et al. Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing. BMC Infect Dis. 2016, Aug;16(1):423. https:\/\/doi.org\/10.1186\/s12879-016-1766-x. PMID: 27534745; PMCID: PMC4989517.","journal-title":"BMC Infect Dis"},{"key":"13313_CR51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijid.2016.03.021","volume":"46","author":"QM Trinh","year":"2016","unstructured":"Trinh QM, Nguyen HL, Do TN, Nguyen VN, Nguyen BH, Nguyen TV, et al. Tuberculosis and HIV co-infection in Vietnam. Int J Infect Dis. 2016, May;46:56\u201360. https:\/\/doi.org\/10.1016\/j.ijid.2016.03.021. Epub 2016 Mar 29. PMID: 27044521.","journal-title":"Int J Infect Dis"},{"key":"13313_CR52","doi-asserted-by":"publisher","unstructured":"Nguyen HB, Nguyen CV, Tran HTG, Nguyen HV, Bui QTT. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011. WPSAR. 7(2):35\u201340. https:\/\/doi.org\/10.5365\/WPSAR.2016.7.2.002. 2016 Jun 8. PMID: 27508089; PMCID: PMC4957611.","DOI":"10.5365\/WPSAR.2016.7.2.002"},{"issue":"1","key":"13313_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13756-016-0129-0","volume":"5","author":"G Thapa","year":"2016","unstructured":"Thapa G, Pant ND, Khatiwada S, Lekhak B, Shrestha B. Drug susceptibility patterns of the Mycobacterium tuberculosis isolated from previously treated and new cases of pulmonary tuberculosis at German-nepal tuberculosis project laboratory, Kathmandu, Nepal. Antimicrob Resist Infect Control. 2016, Aug, 31;5(1):30. https:\/\/doi.org\/10.1186\/s13756-016-0129-0. PMID: 27583136; PMCID: PMC5006423.","journal-title":"Antimicrob Resist Infect Control"},{"key":"13313_CR54","doi-asserted-by":"publisher","unstructured":"Villegas L, Otero L, Sterling TR, Huaman MA, Van der Stuyft P, Gotuzzo E, et al. Prevalence, risk factors, and treatment outcomes of isoniazid- and rifampicin- Mono-resistant pulmonary tuberculosis in Lima, Peru. PLoS One. 2016, Apr, 5;11(4):e0152933. https:\/\/doi.org\/10.1371\/journal.pone.0152933. PMID: 27045684; PMCID: PMC4821555.","DOI":"10.1371\/journal.pone.0152933"},{"key":"13313_CR55","doi-asserted-by":"publisher","unstructured":"Hattori T, Kobayashi N, Nagai H, Chagan-Yasutan H, Telan E, Solante MB. Nationwide HIV-, MDR-TB survey in Japan and collaborative study in the Philippines. Int J Mycobacteriol. 2016, Dec;5(Suppl, 1):S18\u201319. https:\/\/doi.org\/10.1016\/j.ijmyco.2016.09.009. Epub 2016 Oct 22. PMID: 28043540.","DOI":"10.1016\/j.ijmyco.2016.09.009"},{"issue":"4","key":"13313_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/jgid.jgid_167_16","volume":"9","author":"P Sinha","year":"2017","unstructured":"Sinha P, Srivastava GN, Gupta A, Anupurba S. Association of risk factors and drug resistance pattern in tuberculosis patients in North India. J Global Infect Dis. 2017, Oct-Dec;9(4):139\u201345. https:\/\/doi.org\/10.4103\/jgid.jgid_167_16. PMID: 29302148; PMCID: PMC5750437.","journal-title":"J Global Infect Dis"},{"issue":"1","key":"13313_CR57","doi-asserted-by":"publisher","first-page":"10","DOI":"10.37757\/MR2017.V19.N1.3","volume":"19","author":"D Lemus","year":"2017","unstructured":"Lemus D, Echemend\u00eda M, D\u00edaz R, Llanes MJ, Su\u00e1rez L, Marrero A. Antituberculosis drug resistance in pulmonary isolates of Mycobacterium tuberculosis, Cuba 2012-2014. MEDICC Rev. 2017, Jan;19(1):10\u201315. https:\/\/doi.org\/10.37757\/MR2017.V19.N1.3. PMID: 28225540.","journal-title":"MEDICC Rev"},{"issue":"1","key":"13313_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5588\/ijtld.16.0384","volume":"21","author":"S Banu","year":"2017","unstructured":"Banu S, Rahman MT, Ahmed S, Khatun R, Ferdous SS, Hosen B, et al. Multidrug-resistant tuberculosis in Bangladesh: results from a sentinel surveillance system. Int J Tuberc Lung Dis. 2017, Jan, 1;21(1):12\u201317. https:\/\/doi.org\/10.5588\/ijtld.16.0384. PMID: 28157459.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"13313_CR59","doi-asserted-by":"publisher","first-page":"68","DOI":"10.15562\/bmj.v7i1.813","volume":"7","author":"R Kusumawati","year":"2018","unstructured":"Kusumawati R, Tania T, McNeil E, Chongsuvivatwong V. Predictors of multidrug resistance among pulmonary tuberculosis patients in a tertiary hospital in North Sumatera, Indonesia. Bali Med J. 2018;7(1):68\u201373. https:\/\/doi.org\/10.15562\/bmj.v7i1.813.","journal-title":"Bali Med J"},{"issue":"2","key":"13313_CR60","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5588\/ijtld.17.0254","volume":"22","author":"E Pavlenko","year":"2018","unstructured":"Pavlenko E, Barbova A, Hovhannesyan A, Tsenilova Z, Slavuckij A, Shcherbak-Verlan B, et al. Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey. Int J Tuberc Lung Dis. 2018, Feb, 1;22(2):197\u2013205. https:\/\/doi.org\/10.5588\/ijtld.17.0254. PMID: 29506617.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13313_CR61","doi-asserted-by":"publisher","unstructured":"Sam S, Shapiro AE, Sok T, Khann S, So R, Khem S, et al. Initiation, scale-up and outcomes of the Cambodian national MDR-TB programme 2006\u20132016: hospital and community-based treatment through an NGO\u2013NTP partnership. BMJ Open Resp Res. 2018, Jun, 4;5(1):e000256. https:\/\/doi.org\/10.1136\/bmjresp-2017-000256. PMID: 29955361; PMCID: PMC6018896.","DOI":"10.1136\/bmjresp-2017-000256"},{"issue":"1","key":"13313_CR62","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12879-018-3053-5","volume":"18","author":"A Forson","year":"2018","unstructured":"Forson A, Kwara A, Kudzawu S, Omari M, Otu J, Gehre F, et al. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens. BMC Infect Dis. 2018, Apr, 2;18(1):149. https:\/\/doi.org\/10.1186\/s12879-018-3053-5. PMID: 29606091; PMCID: PMC5879759.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13313_CR63","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12879-018-3009-9","volume":"18","author":"A Oudghiri","year":"2018","unstructured":"Oudghiri A, Karimi H, Chetioui F, Zakham F, Bourkadi JE, Elmessaoudi MD, et al. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco. BMC Infect Dis. 2018, Feb, 27;18(1):98. https:\/\/doi.org\/10.1186\/s12879-018-3009-9. PMID: 29486710; PMCID: PMC5830342.","journal-title":"BMC Infect Dis"},{"key":"13313_CR64","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jgar.2017.09.017","volume":"12","author":"W Ennassiri","year":"2018","unstructured":"Ennassiri W, Jaouhari S, Sabouni R, Cherki W, Charof R, Filali-Maltouf A, et al. Analysis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis isolates in Morocco using GenoType\u00ae MTBDRplus assay. J Glob Antimicrob Resist. 2018, Mar;12:197\u2013201. https:\/\/doi.org\/10.1016\/j.jgar.2017.09.017. Epub 2017 Oct 7. PMID: 28993300.","journal-title":"J Glob Antimicrob Resist"},{"key":"13313_CR65","doi-asserted-by":"publisher","unstructured":"Li Q, Zhao G, Wu L, Lu M, Liu W, Wu Y, et al. Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China. Antimicrob Resist Infect Control. 2018, May, 2;7(1):7: 61. https:\/\/doi.org\/10.1186\/s13756-018-0348-7. PMID: 29744042; PMCID: PMC5930636.","DOI":"10.1186\/s13756-018-0348-7"},{"key":"13313_CR66","doi-asserted-by":"publisher","unstructured":"Mesfin EA, Beyene D, Tesfaye A, Admasu A, Addise D, Amare M, et al. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS One. 2018, Jun, 4;13(6):e0197737. https:\/\/doi.org\/10.1371\/journal.pone.0197737. PMID: 29864118; PMCID: PMC5986145.","DOI":"10.1371\/journal.pone.0197737"},{"issue":"1","key":"13313_CR67","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13756-018-0306-4","volume":"7","author":"M Al Ammari","year":"2018","unstructured":"Al Ammari M, Al Turaiki A, Al Essa M, Kashkary AM, Eltigani SA, Ahmed AE. Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014\u20132015. Antimicrob Resist Infect Control. 2018, Jan;7(1):12. https:\/\/doi.org\/10.1186\/s13756-018-0306-4. PMID: 29387346; PMCID: PMC5778613.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"13313_CR68","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/ijmr.IJMR_1220_17","volume":"149","author":"R Sharma","year":"2019","unstructured":"Sharma R, Sharma SK, Singh BK, Mittal A, Kumar P. High degree of fluoroquinolone resistance among pulmonary tuberculosis patients in New Delhi, India. The Indian J Med Res. 2019, Jan;149(1):62\u201366. https:\/\/doi.org\/10.4103\/ijmr.IJMR_1220_17. PMID: 31115377; PMCID: PMC6507539.","journal-title":"The Indian J Med Res"},{"issue":"1","key":"13313_CR69","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1186\/s12879-019-4375-7","volume":"19","author":"BP Tembo","year":"2019","unstructured":"Tembo BP, Malangu NG. Prevalence and factors associated with multidrug\/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana. BMC Infect Dis. 2019, Sep, 6;19(1):779. https:\/\/doi.org\/10.1186\/s12879-019-4375-7. PMID: 31492099; PMCID: PMC6728949.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"13313_CR70","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S1473-3099(18)30673-X","volume":"19","author":"K Z\u00fcrcher","year":"2019","unstructured":"Z\u00fcrcher K, Ballif M, Fenner L, Borrell S, Keller PM, Gnokoro J, et al. International epidemiology databases to evaluate AIDS (IeDEA) consortium. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study. The Lancet Infect Dis. 2019, Mar;19(3):298\u2013307. https:\/\/doi.org\/10.1016\/S1473-3099(18)30673-X. Epub 2019 Feb 8. PMID: 30744962; PMCID: PMC6482382.","journal-title":"The Lancet Infect Dis"},{"issue":"1","key":"13313_CR71","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12879-019-4189-7","volume":"19","author":"O Oliveira","year":"2019","unstructured":"Oliveira O, Gaio R, Carvalho C, Correia-Neves M, Duarte R, Rito T. A nationwide study of multidrug-resistant tuberculosis in Portugal 2014\u20132017 using epidemiological and molecular clustering analyses. BMC Infect Dis. 2019, Jul, 1;19(1):567. https:\/\/doi.org\/10.1186\/s12879-019-4189-7. PMID: 31262256; PMCID: PMC6604307.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13313_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5588\/ijtld.18.0231","volume":"23","author":"ML Aznar","year":"2019","unstructured":"Aznar ML, Rando-Segura A, Moreno MM, Soley ME, Igual ES, Bocanegra C, et al. Prevalence and risk factors of multidrug-resistant tuberculosis in Cubal, Angola: a prospective cohort study. Int J Tuberc Lung Dis. 2019, Jan, 1;23(1):67\u201372. https:\/\/doi.org\/10.5588\/ijtld.18.0231. PMID: 30674377.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2019","key":"13313_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2923549","volume":"2019","author":"K Mehari","year":"2019","unstructured":"Mehari K, Asmelash T, Hailekiros H, Wubayehu T, Godefay H, Araya T, et al. Prevalence and factors associated with multidrug-resistant tuberculosis (MDR-TB) among presumptive MDR-TB patients in Tigray Region, Northern Ethiopia. Can J Infect Dis Med Microbiol. 2019, Sep;2019(2019):1\u20138. https:\/\/doi.org\/10.1155\/2019\/2923549. PMID: 31583034; PMCID: PMC6754863.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"13313_CR74","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/tmi.13205","volume":"24","author":"V Iem","year":"2019","unstructured":"Iem V, Dean A, Zignol M, Vongvichit P, Inthavong D, Siphanthong S, et al. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey. Trop Med Int Health. 2019, Apr;24(4):421\u201331. https:\/\/doi.org\/10.1111\/tmi.13205. Epub 2019 Jan 31. PMID: 30663180.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"13313_CR75","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5588\/ijtld.19.0173","volume":"24","author":"MP Chen","year":"2020","unstructured":"Chen MP, Miramontes R, Kammerer JS. Multidrug-resistant tuberculosis in the United States, 2011\u20132016: patient characteristics and risk factors. Int J Tuberc Lung Dis. 2020, Jan, 1;24(1):92\u201399. https:\/\/doi.org\/10.5588\/ijtld.19.0173. PMID: 32005311; PMCID: PMC8116816.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13313_CR76","doi-asserted-by":"publisher","unstructured":"Hirama T, Sabur N, Derkach P, McNamee J, Song H, Marras T, et al. Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010\u20132016. CCDR. 46(4):84\u201392. https:\/\/doi.org\/10.14745\/ccdr.v46i04a05. 2020 Apr 2. PMID: 32281986; PMCID: PMC7145431.","DOI":"10.14745\/ccdr.v46i04a05"},{"key":"13313_CR77","doi-asserted-by":"crossref","unstructured":"Fildan AP, Arghir IA, Popescu GG, et al. The prevalence and spectrum of Mycobacterium tuberculosis chemoresistance among TB patients. Farmacia- official journal of the Romanian society of pharmaceutical sciences. 2020. Available from: https:\/\/farmaciajournal.com\/issue-articles\/the-prevalence-and-spectrum-of-mycobacterium-tuberculosis-chemoresistance-among-tb-patients\/.","DOI":"10.31925\/farmacia.2020.1.18"},{"issue":"1","key":"13313_CR78","doi-asserted-by":"publisher","first-page":"17552","DOI":"10.1038\/s41598-020-74432-y","volume":"10","author":"SS Shivekar","year":"2020","unstructured":"Shivekar SS, Kaliaperumal V, Brammacharry U, Sakkaravarthy A, Raj CKV, Alagappan C, et al. Prevalence and factors associated with multidrug-resistant tuberculosis in South India. Sci Rep. 2020, Oct, 16;10(1):17552. https:\/\/doi.org\/10.1038\/s41598-020-74432-y. PMID: 33067551; PMCID: PMC7567814.","journal-title":"Sci Rep"},{"key":"13313_CR79","doi-asserted-by":"publisher","unstructured":"Tilloeva Z, Aghabekyan S, Davtyan K, Goncharova O, Kabirov O, Pirmahmadzoda B, et al. Tuberculosis in key populations in Tajikistan \u2013 a snapshot in 2017. J Infect Dev Ctries. 2020, Nov;14(11.1):94S\u2013100S. https:\/\/doi.org\/10.3855\/jidc.11952. PMID: 33226966.","DOI":"10.3855\/jidc.11952"},{"issue":"8","key":"13313_CR80","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3855\/jidc.12319","volume":"14","author":"B Manyame-Murwira","year":"2020","unstructured":"Manyame-Murwira B, Takarinda KC, Thekkur P, Payera B, Mutunzi H, Simbi R, et al. Prevalence, risk factors and treatment outcomes of isoniazid resistant TB in Bulawayo city, Zimbabwe: a cohort study. J Infect Dev Ctries. 2020, Aug, 31;14(8):893\u2013900. https:\/\/doi.org\/10.3855\/jidc.12319. PMID: 32903234; PMCID: PMC8655986.","journal-title":"J Infect Dev Ctries"},{"key":"13313_CR81","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.2147\/IDR.S277477","volume":"13","author":"MFMK Sambas","year":"2020","unstructured":"Sambas MFMK, Rabbani U, Al-Gethamy MMM, Surbaya SH, Alharbi FFI, Ahmad RGA, et al. Prevalence and Determinants of Multidrug-Resistant Tuberculosis in Makkah, Saudi Arabia. IDR. 2020 Nov, 10, 13: 4031\u201338. doi: https:\/\/doi.org\/10.2147\/IDR.S277477. PMID: 33204120; PMCID: PMC7667158.","journal-title":"IDR"},{"issue":"1","key":"13313_CR82","doi-asserted-by":"publisher","first-page":"2508283","DOI":"10.1155\/2020\/2508283","volume":"2020","author":"JB Baluku","year":"2020","unstructured":"Baluku JB, Mugabe P, Mulwana R, Nassozi S, Katuramu R, Worodria W. High prevalence of rifampicin resistance associated with Rural residence and very Low bacillary load among TB\/HIV-coinfected patients at the national tuberculosis treatment center in Uganda. Biomed Res Int. 2020, Jul;2020(1):2508283. https:\/\/doi.org\/10.1155\/2020\/2508283. PMID: 32775411; PMCID: PMC7397442.","journal-title":"Biomed Res Int"},{"issue":"7","key":"13313_CR83","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/tmi.13409","volume":"25","author":"LH Arroyo","year":"2020","unstructured":"Arroyo LH, Yamamura M, Ramos ACV, Campoy LT, Crispim JDA, Berra TZ, et al. Determinants of multidrug-resistant tuberculosis in S\u00e3o Paulo\u2014Brazil: a multilevel Bayesian analysis of factors associated with individual, community and access to health services. Trop Med Int Health. 2020, Jul;25(7):839\u201349. https:\/\/doi.org\/10.1111\/tmi.13409. Epub 2020 May 28. PMID: 32358845; PMCID: PMC7383622.","journal-title":"Trop Med Int Health"},{"key":"13313_CR84","doi-asserted-by":"publisher","unstructured":"Welekidan LN, Skjerve E, Dejene TA, Gebremichael MW, Brynildsrud O, Agdestein A, et al. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: a cross-sectional study. PLoS One. 15(8):e0236362. doi: 10.1371\/journal.pone.0236362.Erratum in:PLoS One.2021 Oct 6; 16(10):e0258457.doi https:\/\/doi.org\/10.1371\/journal.pone.0236362. 2020 Aug 14. PMID: 32797053; PMCID: PMC7428183.","DOI":"10.1371\/journal.pone.0236362"},{"issue":"2","key":"13313_CR85","doi-asserted-by":"publisher","first-page":"102","DOI":"10.22317\/jcms.v7i2.955","volume":"7","author":"ZAY Al-Khayat","year":"2021","unstructured":"Al-Khayat ZAY, Agha NFS, Majeed PD, Alharmni KIF, Agha DNF. Prevalence of HIV among newly diagnosed tuberculosis patients in Erbil Governorate, Iraq. J Contemp Med Sci. 2021;7(2):102\u201307. https:\/\/doi.org\/10.22317\/jcms.v7i2.955.","journal-title":"J Contemp Med Sci"},{"issue":"38","key":"13313_CR86","doi-asserted-by":"publisher","first-page":"203","DOI":"10.11604\/pamj.2021.38.203.19034","volume":"38","author":"FE Ejeh","year":"2021","unstructured":"Ejeh FE, Undiandeye A, Okon K, Moshood KH. Prevalence of rifampicin resistance tuberculosis among HIV\/TB coinfected patients in Benue State, Nigeria. Pan Afr Med J. 2021, Feb;38(38):203. https:\/\/doi.org\/10.11604\/pamj.2021.38.203.19034. PMID: 33995809; PMCID: PMC8106797.","journal-title":"Pan Afr Med J"},{"issue":"1","key":"13313_CR87","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1186\/s12879-021-06296-0","volume":"21","author":"M Seifert","year":"2021","unstructured":"Seifert M, Aung HT, Besler N, Harris V, Mar TT, Colman RE, et al. Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB\/RIF. BMC Infect Dis. 2021, Aug, 9;21(1):781. https:\/\/doi.org\/10.1186\/s12879-021-06296-0. PMID: 34372793; PMCID: PMC8351356.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"13313_CR88","doi-asserted-by":"publisher","first-page":"728","DOI":"10.15537\/smj.2021.42.7.20200797","volume":"42","author":"MS Al-Shahrani","year":"2021","unstructured":"Al-Shahrani MS, Hakami MI, Younis MA, Fan HA, Jeraiby MA, Alraey Y. Prevalence of primary anti-tuberculosis drug resistance at the tertiary center in Saudi Arabia and associated risk factors. SMJ. 2021, Jul;42(7):728\u201334. https:\/\/doi.org\/10.15537\/smj.2021.42.7.20200797. PMID: 34187916; PMCID: PMC9195529.","journal-title":"SMJ"},{"key":"13313_CR89","doi-asserted-by":"publisher","unstructured":"Sylverken AA, Kwarteng A, Twumasi-Ankrah S, Owusu M, Arthur RA, Dumevi RM, et al. The burden of drug resistance tuberculosis in Ghana; results of the first national survey. PLoS One. 2021, Jun, 10;16(6):e0252819. https:\/\/doi.org\/10.1371\/journal.pone.0252819. PMID: 34111159; PMCID: PMC8191906.","DOI":"10.1371\/journal.pone.0252819"},{"issue":"1","key":"13313_CR90","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/tmi.13502","volume":"26","author":"P Kamolwat","year":"2021","unstructured":"Kamolwat P, Nateniyom S, Chaiprasert A, Disratthakit A, Mahasirimongkol S, Yamada N, et al. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey. Trop Med Int Health. 2021, Jan;26(1):45\u201353. https:\/\/doi.org\/10.1111\/tmi.13502. Epub 2020 Nov 8. PMID: 32997863.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"13313_CR91","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1186\/s12879-021-06887-x","volume":"21","author":"MO Ogwang","year":"2021","unstructured":"Ogwang MO, Imbuga M, Ngugi C, Mutharia L, Magoma G, Diero L. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya. BMC Infect Dis. 2021, Nov, 22;21(1):1175. https:\/\/doi.org\/10.1186\/s12879-021-06887-x. PMID: 34809602; PMCID: PMC8607708.","journal-title":"BMC Infect Dis"},{"key":"13313_CR92","doi-asserted-by":"publisher","unstructured":"Al-Hayani AM, Kamel SA, Almudarra SS, Alhayani M, Abu-Zaid A. Drug resistance to anti-tuberculosis drugs: a cross-sectional study from Makkah, Saudi Arabia. Cureus. 2021, Aug, 10;13(8):e17069. https:\/\/doi.org\/10.7759\/cureus.17069. PMID: 34522547; PMCID: PMC8428200.","DOI":"10.7759\/cureus.17069"},{"issue":"26","key":"13313_CR93","doi-asserted-by":"publisher","first-page":"100292","DOI":"10.1016\/j.jctube.2021.100292","volume":"26","author":"M Doh\u00e1l","year":"2022","unstructured":"Doh\u00e1l M, Dvo\u0159\u00e1kov\u00e1 V, \u0160perkov\u00e1 M, Porvazn\u00edk I, Cabibbe AM, Trovato A, et al. Anti-tuberculosis drug resistance in Slovakia, 2018\u20132019: the first whole-genome epidemiological study. J Educ Chang Clin Tuberc Other Mycobact Dis. 2022, Dec;26(26):100292. https:\/\/doi.org\/10.1016\/j.jctube.2021.100292. PMID: 35005254; PMCID: PMC8717600.","journal-title":"J Educ Chang Clin Tuberc Other Mycobact Dis"},{"issue":"14","key":"13313_CR94","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2147\/IDR.S294611","volume":"Volume 14","author":"L Du","year":"2021","unstructured":"Du L, Zhang Y, Lv X, Duan Y, Shi X, Ji H, et al. Prevalence of multidrug-resistant tuberculosis in Dalian, China: a retrospective study. IDR. 2021, Mar;Volume 14(14):1037\u201347. https:\/\/doi.org\/10.2147\/IDR.S294611. PMID: 33758518; PMCID: PMC7981151.","journal-title":"IDR"},{"key":"13313_CR95","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.2147\/IDR.S327607","volume":"14","author":"K Diriba","year":"2021","unstructured":"Diriba K, Awulachew E, Churiso G. The magnitude of MTB and rifampicin resistance MTB using Xpert-MTB\/RIF assay among tuberculosis suspected patients in Gedeo Zone, Southern Ethiopia. IDR. 2021, Sep, 24;14:3961\u201369. https:\/\/doi.org\/10.2147\/IDR.S327607. PMID: 34594119; PMCID: PMC8478339.","journal-title":"IDR"},{"issue":"10","key":"13313_CR96","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/hiv.13318","volume":"23","author":"K Anderson","year":"2022","unstructured":"Anderson K, Pietersen E, Shepherd BE, Bian A, Dheda K, Warren R, et al. High mortality among patients hospitalized for drug-resistant tuberculosis with acquired second-line drug resistance and high HIV prevalence. HIV Med. 2022, Nov;23(10):1085\u201397. https:\/\/doi.org\/10.1111\/hiv.13318. Epub 2022 May 24. PMID: 35608016; PMCID: PMC9588462.","journal-title":"HIV Med"},{"issue":"15","key":"13313_CR97","doi-asserted-by":"publisher","first-page":"7241","DOI":"10.2147\/IDR.S386497","volume":"Volume 15","author":"AMH Dirie","year":"2022","unstructured":"Dirie AMH, \u00c7olako\u011flu S, Abdulle OM, Abdi BM, Osman MA, Shire AM, et al. Prevalence of multidrug-resistant TB among smear-positive pulmonary TB patients in Banadir, Somalia: a multicenter study. IDR. 2022, Dec;Volume 15(15):7241\u201348. https:\/\/doi.org\/10.2147\/IDR.S386497. PMID: 36533250; PMCID: PMC9749408.","journal-title":"IDR"},{"issue":"3","key":"13313_CR98","doi-asserted-by":"publisher","first-page":"371","DOI":"10.33073\/pjm-2022-033","volume":"71","author":"D Luo","year":"2022","unstructured":"Luo D, Yu S, Huang Y, Zhan J, Chen Q, Yan L, et al. Recent transmission and Prevalent characterization of the Beijing family Mycobacterium tuberculosis in Jiangxi, China. Pol J Microbiol. 2022, Sep, 24;71(3):371\u201380. https:\/\/doi.org\/10.33073\/pjm-2022-033. PMID: 36185019; PMCID: PMC9608159.","journal-title":"Pol J Microbiol"},{"issue":"2","key":"13313_CR99","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijregi.2022.01.004","volume":"2","author":"FA Mphande-Nyasulu","year":"2022","unstructured":"Mphande-Nyasulu FA, Puengpipattrakul P, Praipruksaphan M, Keeree A, Ruanngean K. Prevalence of tuberculosis (TB), including multi-drug-resistant and extensively-drug-resistant TB, and association with occupation in adults at Sirindhorn hospital, Bangkok. IJID Regions. 2022, Jan;2(2):141\u201348. https:\/\/doi.org\/10.1016\/j.ijregi.2022.01.004. PMID: 35757070; PMCID: PMC9216408.","journal-title":"IJID Regions"},{"issue":"10","key":"13313_CR100","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/tmi.13814","volume":"27","author":"BK Mutayoba","year":"2022","unstructured":"Mutayoba BK, Ershova J, Lyamuya E, Hoelscher M, Heinrich N, Kilale AM, et al. The second national anti-tuberculosis drug resistance survey in Tanzania, 2017\u20132018. Trop Med Int Health. 2022, Oct;27(10):891\u2013901. https:\/\/doi.org\/10.1111\/tmi.13814. Epub 2022 Sep 11. PMID: 36089572; PMCID: PMC9826299.","journal-title":"Trop Med Int Health"},{"issue":"6","key":"13313_CR101","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1513\/AnnalsATS.202105-580OC","volume":"19","author":"Y Liu","year":"2022","unstructured":"Liu Y, Posey DL, Yang Q, Weinberg MS, Maloney SA, Lambert LA, et al. Multidrug-resistant tuberculosis in U.S.-bound immigrants and refugees. Ann Am Thorac Soc. 2022, Jun;19(6):943\u201351. https:\/\/doi.org\/10.1513\/AnnalsATS.202105-580OC. PMID: 34941475; PMCID: PMC9169124.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"13313_CR102","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/s12879-022-07598-7","volume":"22","author":"I Bykov","year":"2022","unstructured":"Bykov I, Dyachenko O, Ratmanov P, Liu H, Liang L, Wu Q. Factors contributing to the high prevalence of multidrug-resistance\/rifampicin-resistance in patients with tuberculosis: an epidemiological cross sectional and qualitative study from Khabarovsk krai region of Russia. BMC Infect Dis. 2022, Jul, 13;22(1):612. https:\/\/doi.org\/10.1186\/s12879-022-07598-7. PMID: 35831812; PMCID: PMC9281178.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"13313_CR103","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3855\/jidc.14990","volume":"16","author":"A Iqbal","year":"2022","unstructured":"Iqbal A, Shafique M, Zahoor MA, Muzammil S, Nawaz Z, Jabbar A, et al. The occurrence of multidrug-resistant Mycobacterium tuberculosis from patients of pulmonary tuberculosis. J Infect Dev Ctries. 2022, Apr, 30;16(4):698\u2013704. https:\/\/doi.org\/10.3855\/jidc.14990. PMID: 35544633.","journal-title":"J Infect Dev Ctries"},{"key":"13313_CR104","doi-asserted-by":"publisher","unstructured":"Korzeniewska-Kose\u0142a M, Weso\u0142owski S. Tuberculosis in Poland in 2021. In: Przegl Epidemiol. Vol. 77(4): Polish: English; 2024 May 20. p. 449\u201365. https:\/\/doi.org\/10.32394\/pe.77.37. Epub 2024 Apr 9. PMID: 38783654.","DOI":"10.32394\/pe.77.37"},{"key":"13313_CR105","unstructured":"Division of Tuberculosis Elimination, National Center for HIV (a). Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. November 29, 2021, Available from\" https:\/\/archive.cdc.gov\/#\/details?archive_url=https:\/\/archive.cdc.gov\/www_cdc_gov\/tb\/statistics\/reports\/2021\/table17.htm."},{"issue":"1","key":"13313_CR106","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12879-022-07965-4","volume":"23","author":"M Loukman","year":"2023","unstructured":"Loukman M, Olivier B, Vincent B, Rachid D, Cyril F, Morgane V, et al. Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island. BMC Infect Dis. 2023, Jan, 5;23(1):4. https:\/\/doi.org\/10.1186\/s12879-022-07965-4. PMID: 36604621; PMCID: PMC9814425.","journal-title":"BMC Infect Dis"},{"issue":"13","key":"13313_CR107","doi-asserted-by":"publisher","first-page":"1069292","DOI":"10.3389\/fmicb.2022.1069292","volume":"13","author":"ID Otchere","year":"2023","unstructured":"Otchere ID, Morgan PA, Asare P, Osei-Wusu S, Aboagye SY, Yirenkyi SO, et al. Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases. Front Microbiol. 2023, Jan;13(13):1069292. https:\/\/doi.org\/10.3389\/fmicb.2022.1069292. PMID: 36713197; PMCID: PMC9878308.","journal-title":"Front Microbiol"},{"issue":"3","key":"13313_CR108","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4314\/ahs.v23i3.41","volume":"23","author":"K Omona","year":"2023","unstructured":"Omona K, Opiyo AM. Assessment of risk factors associated with multi-drug resistant tuberculosis (MDR-TB) in Gulu regional referral hospital. Afr H Sci. 2023, Sep;23(3):343\u201357. https:\/\/doi.org\/10.4314\/ahs.v23i3.41. PMID: 38357137; PMCID: PMC10862605.","journal-title":"Afr H Sci"},{"key":"13313_CR109","unstructured":"Division of Tuberculosis Elimination, National Center for HIV (b). Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, November 2023, Reported Tuberculosis in the United States, 2022, Available from: https:\/\/www.cdc.gov\/tb\/statistics\/reports\/2022\/table11.htm."},{"key":"13313_CR110","doi-asserted-by":"publisher","unstructured":"Seid A, Girma Y, Abebe A, Dereb E, Kassa M, Berhane N. Characteristics of TB\/HIV Co-infection and patterns of multidrug-resistance tuberculosis in the Northwest Amhara, Ethiopia. IDR. 2023, Jun;16, 16:3829\u201345. https:\/\/doi.org\/10.2147\/IDR.S412951. PMID: 37346368; PMCID: PMC10281285.","DOI":"10.2147\/IDR.S412951"},{"key":"13313_CR111","doi-asserted-by":"publisher","unstructured":"Wang Z, Hou Y, Guo T, Jiang T, Xu L, Hu H, et al. Epidemiological characteristics and risk factors of multidrug-resistant tuberculosis in Luoyang, China. Front Public Health. 2023, May;11(11):1117101. https:\/\/doi.org\/10.3389\/fpubh.2023.1117101. PMID: 37228738; PMCID: PMC10203519.","DOI":"10.3389\/fpubh.2023.1117101"},{"key":"13313_CR112","unstructured":"National TB Control Programme. COMMON MANAGEMENT UNIT AIDS, TB & MALARIA ministry of National health services, regulations and coordination. 2023. https:\/\/www.cmu.gov.pk\/ntp-national-tb-control-programme\/, Pakistan."},{"issue":"37","key":"13313_CR113","doi-asserted-by":"publisher","first-page":"100466","DOI":"10.1016\/j.jctube.2024.100466","volume":"37","author":"A Okumu","year":"2024","unstructured":"Okumu A, Orwa J, Sitati R, Omondi I, Odhiambo B, Ogoro J, et al. Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya. J Educ Chang Clin Tuberc Other Mycobact Dis. 2024, Aug;37(37):100466. https:\/\/doi.org\/10.1016\/j.jctube.2024.100466. PMID: 39188352; PMCID: PMC11345928.","journal-title":"J Educ Chang Clin Tuberc Other Mycobact Dis"},{"issue":"4","key":"13313_CR114","doi-asserted-by":"publisher","first-page":"528","DOI":"10.32394\/pe.76.48","volume":"76","author":"M Korzeniewska-Kose\u0142a","year":"2023","unstructured":"Korzeniewska-Kose\u0142a M, Weso\u0142owski S. Tuberculosis in Poland in 2020. Przegl Epidemiol. 2023;76(4):528\u201346. https:\/\/doi.org\/10.32394\/pe.76.48. PMID: 37017237.","journal-title":"Przegl Epidemiol"},{"key":"13313_CR115","unstructured":"INDIA TB REPORT 2024. Central TB Division, ministry of health and family welfare. 2024, Available from: March. https:\/\/tbcindia.mohfw.gov.in\/wp-content\/uploads\/2024\/10\/TB-Report_for-Web_08_10-2024-1.pdf."},{"key":"13313_CR116","doi-asserted-by":"publisher","unstructured":"Reta MA, Maningi NE, Fourie PB. Patterns and profiles of drug resistance-conferring mutations in Mycobacterium tuberculosis genotypes isolated from tuberculosis-suspected attendees of spiritual holy water sites in Northwest Ethiopia. Front Public Health. 2024, Mar, 19;12:12: 1356826. https:\/\/doi.org\/10.3389\/fpubh.2024.1356826. PMID: 38566794; PMCID: PMC10985251.","DOI":"10.3389\/fpubh.2024.1356826"},{"key":"13313_CR117","unstructured":"UK Health Security Agency. National quarterly report of tuberculosis in England: quarter 1. 2025, provisional data, Updated 24 April 2025, Available from: https:\/\/www.gov.uk\/government\/statistics\/tuberculosis-in-england-national-quarterly-reports\/national-quarterly-report-of-tuberculosis-in-england-quarter-1-2025-provisional-data."},{"key":"13313_CR118","doi-asserted-by":"publisher","unstructured":"Belay G, Getachew H, Birku T, Tadese A, Gashaw Y, Getie M, et al. Rifampicin-resistant Mycobacterium tuberculosis and unsuccessful results from Xpert\u00ae MTB\/Rif-Ultra assay in Amhara Region, Ethiopia. J Educ Chang Clin Tuberc Other Mycobact Dis. 2025, Apr, 25;40:40: 100528. https:\/\/doi.org\/10.1016\/j.jctube.2025.100528. PMID: 40351513; PMCID: PMC12063118.","DOI":"10.1016\/j.jctube.2025.100528"},{"issue":"1","key":"13313_CR119","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12941-025-00786-8","volume":"24","author":"BB Ngouama","year":"2025","unstructured":"Ngouama BB, Djontu JC, Elion Assiana DO, Mouzinga FH, Dello MNM, Abdul A, et al. Drug-resistant tuberculosis profiles among patients presenting at the antituberculosis center of Brazzaville, Republic of Congo. Ann Clin Microbiol Antimicrob. 2025, May, 9;24(1):31. https:\/\/doi.org\/10.1186\/s12941-025-00786-8. PMID: 40346665; PMCID: PMC12065265.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"13313_CR120","doi-asserted-by":"publisher","first-page":"20251081","DOI":"10.1515\/biol-2025-1081","volume":"20","author":"H Chen","year":"2025","unstructured":"Chen H, Tong Z, Zhong J, Zeng Q, Shen B, Qian F, et al. Epidemiological characteristics and risk factors analysis of multidrug-resistant tuberculosis among tuberculosis population in Huzhou city, Eastern China. Open Life Sci. 2025, Mar, 22;20(1):20251081. https:\/\/doi.org\/10.1515\/biol-2025-1081. PMID: 40129467; PMCID: PMC11931660.","journal-title":"Open Life Sci"},{"issue":"7","key":"13313_CR121","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/tmi.14126","volume":"30","author":"N Han","year":"2025","unstructured":"Han N, Yan L, Yuan M, Chen Z, Zeng Y, Tang H. Characteristics and risk factors of drug-resistant tuberculosis in Sichuan, China: an observational study. Trop Med Int Health. 2025, May, 15;30(7):704\u201311. https:\/\/doi.org\/10.1111\/tmi.14126. Epub ahead of print. PMID: 40371607.","journal-title":"Trop Med Int Health"},{"issue":"Suppl 14","key":"13313_CR122","doi-asserted-by":"publisher","first-page":"100587","DOI":"10.1016\/j.ijregi.2025.100587","volume":"14","author":"A Zumla","year":"2025","unstructured":"Zumla A, Sahu S, Ditiu L, Singh U, Park YJ, Yeboah-Manu D, et al. Inequities underlie the alarming resurgence of tuberculosis as the world\u2019s top cause of death from an Infectious disease - Breaking the silence and addressing the underlying root causes. IJID Regions. 2025, Mar;14(Suppl 14):100587. https:\/\/doi.org\/10.1016\/j.ijregi.2025.100587. PMID: 40201557; PMCID: PMC11973691.","journal-title":"IJID Regions"},{"key":"13313_CR123","doi-asserted-by":"publisher","unstructured":"Sultana ZZ, Hoque FU, Beyene J, Akhlak-Ul-Islam M, Khan MHR, Ahmed S, et al. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 21(1):51. doi: 10.1186\/s12879-020-05749-2.Erratum in:BMC Infect Dis.2021 Jan 20; 21(1):86.doi https:\/\/doi.org\/10.1186\/s12879-020-05749-2. 2021 Jan 11. PMID: 33430786; PMCID: PMC7802168.","DOI":"10.1186\/s12879-020-05749-2"},{"issue":"3","key":"13313_CR124","doi-asserted-by":"publisher","first-page":"1600803","DOI":"10.1183\/13993003.00803-2016","volume":"49","author":"ML Bastos","year":"2017","unstructured":"Bastos ML, Lan Z, Menzies D. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis. Eur Respir J. 2017, Mar, 22;49(3):1600803. https:\/\/doi.org\/10.1183\/13993003.00803-2016. PMID: 28331031.","journal-title":"Eur Respir J"},{"issue":"1","key":"13313_CR125","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1183\/09031936.00205413","volume":"44","author":"AS Dean","year":"2014","unstructured":"Dean AS, Zignol M, Falzon D, Getahun H, Floyd K. HIV and multidrug-resistant tuberculosis: overlapping epidemics. Eur Respir J. 2014, Jul;44(1):251\u201354. https:\/\/doi.org\/10.1183\/09031936.00205413. Epub 2014 Feb 13. PMID: 24525438.","journal-title":"Eur Respir J"},{"issue":"18","key":"13313_CR126","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2147\/IDR.S502302","volume":"Volume 18","author":"I Rukasha","year":"2025","unstructured":"Rukasha I, Kaapu KG, Fortune SM, Lekalakala-Mokaba MR. Treatment outcomes for drug-resistant tuberculosis patients on Bedaquiline-based regimens in a mostly Rural South Africa. IDR. 2025 Apr;Volume 18(18):1819\u201329. https:\/\/doi.org\/10.2147\/IDR.S502302. PMID: 40242388; PMCID: PMC12002397.","journal-title":"IDR"},{"key":"13313_CR127","unstructured":"Tuberculosis in the WHO European Region. 2025, Available from: March 19. 3 July 2025. https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/tuberculosis."},{"key":"13313_CR128","unstructured":"World Health Organization. Global tuberculosis report 2023- 3 July 2025. Geneva: World Health Organization; 2023. ISBN 978-92-4-008385-1. Available from: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2023."},{"key":"13313_CR129","unstructured":"World Health Organization. Global tuberculosis report 2024 - 23 December 2025. Geneva: World Health Organization; 2024. ISBN: 978-92-4-010153-1. Available from: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024."},{"key":"13313_CR130","doi-asserted-by":"publisher","unstructured":"Diriba G, Tola HH, Alemu A, Yenew B, Gamtesa DF, Kebede A. Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: a systematic review and meta-analysis. PLoS One. 2021, Oct, 8;16(10):e0258295. https:\/\/doi.org\/10.1371\/journal.pone.0258295. PMID: 34624050; PMCID: PMC8500428.","DOI":"10.1371\/journal.pone.0258295"},{"issue":"1","key":"13313_CR131","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s44197-025-00360-7","volume":"15","author":"BK Hailu","year":"2025","unstructured":"Hailu BK, Demessie Y, Gessese AT, Dagnaw GG, Dejene H. Multidrug resistance tuberculosis in the context of Co-infection in Ethiopia: a systematic review and meta-analysis. J Epidemiol Glob Health. 2025, Feb, 5;15(1):19. https:\/\/doi.org\/10.1007\/s44197-025-00360-7. PMID: 39909956; PMCID: PMC11799485.","journal-title":"J Epidemiol Glob Health"},{"key":"13313_CR132","unstructured":"WHO African region. Tuberculosis in the WHO African Region: 2023 progress update, September 2023 July 3, 2025. Available from: https:\/\/www.afro.who.int\/sites\/default\/files\/2023-09\/Tuberculosis%20in%20the%20African%20Region_2023%20report.pdf."},{"issue":"1","key":"13313_CR133","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12879-026-12664-5","volume":"26","author":"MJ Sujan","year":"2026","unstructured":"Sujan MJ, Rahman A, Taleb A, Khan AH, Sultana SR, Moni MA, et al. Tuberculosis notification trends and treatment outcomes in Bangladesh: findings from a national TB program data, 2019\u20132021. BMC Infect Dis. 2026, Jan, 31;26(1):464. https:\/\/doi.org\/10.1186\/s12879-026-12664-5. PMID: 41620659; PMCID: PMC12947352.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13313-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13313-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13313-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:36:04Z","timestamp":1780446964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13313-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":133,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13313"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13313-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO; registration number: [CRD420251018331]).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1070"}}